EIF2A and breast carcinoma: Above-mentioned study has suggested that p-eIF2α may inhibit a tumor invasive growth in TNBC, that represents an extremally aggressive breast cancer subtype with a poor prognosis for patients, as well as enhanced expression of p-eIF2α is strictly correlated with weaken tumor invasion of lymph nodes.